An Ace in the Hole...  by Mondragon, Estefania & Maher, L. James
Structure
PreviewsAn Ace in the Hole...Estefania Mondragon1 and L. James Maher III2,*
1Neurobiology of Disease Program, Mayo Graduate School
2Department of Biochemistry and Molecular Biology
Mayo Clinic, 200 First ST SW, Rochester, MN 55905, USA
*Correspondence: maher@mayo.edu
http://dx.doi.org/10.1016/j.str.2012.07.006
In this issue of Structure, Tesmer and coworkers report the structure of a small RNA aptamer in an inhibitory
complexwith aGprotein receptor kinase. The aptamer adopts a charming structure that inserts an adenosine
residue into the ATP binding pocket of the kinase.Guanine nucleotide-binding protein (G
protein)-coupled receptors (GPCRs) are
integral membrane proteins containing
seven membrane-spanning helices and
constitute the most abundant class of sig-
nal transduction receptors in mammals.
GPCR-based machinery is critical for
sensory perception, blood pressure ho-
meostasis, and regulation of heart rate.
These receptors transduce signals from
small molecule binding outside the cell
through activation of cytoplasmic hetero-
trimeric G proteins.Figure 1. G Protein-Coupled Receptor Signaling and RNA Aptamers
(A) G protein-coupled receptor (GPCR) signaling cycle. (I) Ligand (e.g.,
epinephrine, orange) binding induces GPCR (cyan) conformational change in
the presence of assembled G protein a (purple), -b (blue), and -g (green)
subunits. (II) Sensitized receptor signaling involves separation of G protein
subunits triggering kinase cascades. (III) GPCR phosphorylation by GRK
(red). (IV) GPCR desensitization by arrestin (pink) binding.
(B) Schematic SELEX cycles convert a random DNA library to a random RNA
library that is incubated with GRK protein (red) immobilized on beads followed
by partitioning of bound RNA aptamers, recovery, and reverse transcription
back to DNA. Multiple selection cycles are required.
(C) GRK2 coordinates from PBD file 10MW (red) with homology-modeled
bound ATP (yellow) from PDB file 3C4W in the kinase domain.
(D) GRK2-C13.28 RNA aptamer complex highlighting ATP mimicry by an
extruded adenosine residue of the aptamer.An important component of
signal transduction through
GPCRs is signal attenuation
by desensitization of recep-
tors. This process involves
receptor phosphorylation by
regulatory proteins called
(rather awkwardly) heterotri-
meric guanine nucleotide-
binding protein-coupled
receptor kinases (GRKs).
Phosphorylated receptors
are then silenced through
the binding of arrestins
(Figure 1A).
One of the GRKs, GRK2, is
important in regulating heart
muscle through attenuation
of b-adrenergic and musca-
rinic acetylcholine receptors.
There is interest in artificial
regulation of GRK2, a chal-
lenging intracellular target.
Tools for such regulation
could improve laboratory
studies of GRK function, and
could provide leads for new
drugs (Hartig et al., 2002).
Besides small molecule
screening or rational design,
a fascinating nonrational (butnot irrational) approach to protein inhibitor
discovery is provided by the amazing
power of in vitro selection using vast
shape libraries embodied in small, folded
RNAs. These RNA ‘‘aptamers’’ are pro-
duced through a protocol called System-
atic Evolution of Ligands by Exponential
Enrichment (SELEX; Ellington and Szos-
tak, 1990; Tuerk and Gold, 1990). Not
only are RNA aptamers inhibitors them-
selves, but they may suggest approaches
to develop more conventional small
molecule inhibitors (Hafner et al., 2006).Structure 20, August 8, 2012 ªSELEX (Figure 1B) was previously applied
to purified GRK2 protein by Mayer et al.
(2008). Twelve cycles of conventional
SELEX were used to generate specific
anti-GRK2 RNA aptamers.
In this issue of Structure, Tesmer et al.
(2012) provide the structural basis for
understanding one of these fascinating
RNA aptamers termed C13. This RNA
displayed tight binding and potent inhibi-
tory specificity for GRK2 versus other
kinases, making it the strongest such
inhibitor to date (Mayer et al., 2008).2012 ElsevParticularly striking was the
observation that C13 com-
petes with staurosporine (an
ATP analog) for binding to
the kinase domain of GRK2.
The work of Tesmer et al.
(2012) provides a rationale
for these observations.
The reported crystal struc-
tures for C13/GRK2 com-
plexes confirm RNA aptamer
binding to the kinase domain
of GRK2. Most remarkably,
the structures reveal that an
extruded adenosine residue
in the aptamer provides an
ATP mimic that binds in the
ATP binding site of the GRK2
kinase domain (compare Fig-
ure 1C with Figure 1D). This
ATP mimicry is striking and
perfectly explains the obser-
vation that staurosporine
competes with aptamer bind-
ing (Mayer et al., 2008).
Also revealed in the new
crystal structure is evidence
that other components of the
aptamer sequence make pro-
tein-selective contacts with
GRK2, explaining the abilityier Ltd All rights reserved 1285
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Previewsof the C13 aptamer to distinguish
between kinases.
There are two themes of special interest
highlighted in this work. The first is RNA
mimicry. The mimicry of ATP in this case
adds to examples of RNA’s chameleon
characteristics, which include its ability
to mimic double-stranded DNA (Reiter
et al., 2008). Mimicry of ATP is also note-
worthy, since artificial RNA aptamers
have been developed to bind ATP (Feigon
et al., 1996), and nature has accom-
plished the same kind of feat with nucleo-
tide-specific riboswitches (Mandal and
Breaker, 2004). Second, the GRK2/C13
complex crystallizes with GRK2 in a
conformation altered somewhat from
what had been observed in the absence
of the RNA (Lodowski et al., 2003). This
result confirms the previous observation
that aptamer binding can stabilize a non-
native (or less common) protein confor-
mation (Huang et al., 2003). Such a result
might suggest new strategies for stabi-
lizing inactive protein conformations with
small molecules.
While the present work is illuminating
and exciting, limitations of the studymight
be overcome in the future. Only portions1286 Structure 20, August 8, 2012 ª2012 Elsof the RNA aptamer are adequately
resolved in these structures, bringing
focus onto the extruded adenosine as
ATP mimic, but leaving uncertainty about
the details of the specificity of cationic
amino acid contacts with the phospho-
diester backbone of the aptamer. Also of
interest, but unresolved, is the problem
of comparing the free and bound forms
of the aptamer to understand how ap-
tamer folding changes upon protein
binding and if the extruded adenosine is
an intrinsic feature of the unbound RNA
structure. Such studies comparing free
and protein-complexed aptamer confor-
mations are unusual (Huang et al., 2003;
Reiter et al., 2008).
This work provides an elegant example
of how a nucleotide in a folded RNA can
mimic a free nucleotide triphosphate,
showing how an RNA aptamer drives
specific inhibitory complex formation
with a target kinase using an ‘‘ace in the
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In this issue of Structure, Lerch and colleagues present a 4.5 A˚ cryo electron microscopy (cryoEM) structure
of a variant of an adeno-associated virus that has been genetically engineered for liver gene therapy. The
identification of two structurally distinct loops flanking the highly conserved jellyroll b barrel highlights the
potentials of high-resolution cryoEM.Adeno-associated viruses (AAV) are
small single-stranded DNA viruses of the
Dependovirus genus in the Parvoridae
family. Engineered AAV variants have
been optimized as potential gene delivery
vehicles, thanks to their non-inflammatoryand non-pathogenic properties, wide cell
tropism, and ease of large scale produc-
tion (Mingozzi and High, 2011). Just last
month, the European Medicine Agency
recommended approval of an engineered
AAV variant to treat lipoprotein lipase defi-ciency, the first time for the field of gene
therapy.
AAV is among the smallest spherical
viruses, with a diameter of just 250 A˚. Its
capsid shell is made of 60 viral protein
subunits arranged on a T = 1 icosahedral
